维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Haas SL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The role of CaMKII in calcium-activated death pathways in bone marrow B cells显示文摘	Bissonnette SL Haas A Mann KK	2010	ToxicolSci2010，118，1：	1
2	Biomarker results from the AVADO Phase 3 trial of first - line bevacizumab plus docetaxel for HER - 2 - negative metastatic breast cancer显示文摘	Miles DW De Haas SL Dirix LY	2013	Br J Cancer2013，108，5：	1
3	The role of CaMKII incalcium-activated death pathways in bone marrow B cells显示文摘	Bissonnette SL Haas A Mann KK	2010	ToxicolSci2010，118，1：	1
4	Orexiin receptor antagonism:an ascending multiple--dose study with almorex- ant显示文摘	Hoever P de Haas SL Dorffner G	2012	J Psychopharmaclo2012，26，8：	1
5	High plasma concentractions of human urotensin II do not alter local or systemic hemodynamics in man显示文摘	Wilkinson IB Affolter JT Haas SL	2002	Cardiovasc Res2002，53，2：	1
6	Alcohol consumption and di- gestive tract cancer 显示文摘	Haas SL Ye W Lohr JM	2012	Current Opinion in Clinical Nu- trition and Metabolic Care2012，15，5：	1
7	Transforming growth factor-beta induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5pathway显示文摘	Haas SL Fitzner B Jaster R	2009	Growth Factors2009，27，5：	1
8	Mechanical retardation of bone growth显示文摘	Haas SL	1948	J Bone Joint Surg Am1948，30，：	1
9	Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer显示文摘	Miles DW de Haas SL Dirix LY	2013	Br J Cancer2013，108，5：	1
10	High plasma Concentrations of human urotensin Ⅱ do not alter local or system Ic hemodynamics in man显示文摘	Wilkinson 1B Affolter JT de Haas SL	2002	Cardiovasc Res2002，53，2：	1
11	Biomarker results from the AVADO phase 3 trial of first--line bevacizumab plus docetax- el for HER2-negative metastatic breast cancer显示文摘	Miles DW de Haas SL Dirix LY	2013	Br J Cancer2013，108，5：	1
12	High plasma concentrations of human urotensin Ⅱ do not alter local or systemic hemodynamics in man显示文摘	Wilkinson IB Affolter J-T de Haas SL	2002	Cardiovasc Res2002，53，2：	1
13	Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus 显示文摘	Nierman WC Pain A Anderson MJ Wortman JR Kim HS Arroyo J Berriman M Abe K Archer DB Bermejo C Bennett J Bowyer P Chen D Collins M Coulsen R Davies R Dyer PS Farman M Fedorova N Fedorova N Feldblyum TV Fischer R Fosker N Fraser A Garcla JL Garcia MJ Goble A Goldman GH Gomi K Griffith- Jones S Gwilliam R Haas B Haas H Harris D Horiuchi H Huang J Humphray S Jim6nez J Keller N Khouri H Kitamoto K Kobayashi T Konzack S Kulkarni R Kumagai T Lafon A Latgo JP Li W Lord A Lu C Majoros WH May GS Miller BL Mohamoud Y Molina M Monod M Mouyna I Mulligan S Murphy L O'Neil S Paulsen I Pefialva MA Pertea M Price C Pritchard BL Quail MA Rabbinowitsch E Rawlins N Rajandream MA Reichard U Renauld H Robson GD Rodriguez de Cordoba S Rodriguez-Pefia JM Ronning CM Putter S Salzberg SL Sanchez M Sfnchez-Ferrero JC Saunders D Seeger K Squares R Squares S Takeuchi M Tekaia F Turner G Vazquez de Aldana CR Weidman J White O Woodward J Yu JH Fraser C Galagan JE Asai K Machida M Hall N Barrell B Denning DW	2005	Nature2005，438，7071：	1
14	High plasma concentrations of human urotensin Ⅱ do not alter local or systemic hemodynamics in man显示文摘	Wilkinson IB Affolter JT de Haas SL	2002	Cardiovasc Res2002，53，2：	1
15	High plasma concentrations of human urotensin Ⅱ do not alter local or systemic hemodynamics in man显示文摘	Wilkinson IB Affolter JT de Haas SL Pellegrini MP Boyd J Winter MJ	2002	Cardiovasc Res2002，53，2：	1
16	Treatment of permanent paralysis of deltoid muscle显示文摘	Haas SL	1935	JAMA1935，104，2：	1
17	High plasma concentrations of human urotensin Ⅱ do not alter local or systemic hemodynamics in man 显示文摘	Wilkinson IB Affoher JT de Haas SL	2002	Cardiovase Res2002，53，：	1
18	High plasma concentra- tions of human urotensin II do not alter local or systemic hemody- namics in man 显示文摘	Wilkinson IB Affoher JT de Haas SL	2002	Cardiovasc Res2002，53，2：	1
19	Glutamate release by primary brain tumors induces epileptic activity显示文摘	Buckingham SC Campbell SL Haas BR		0，，10：	1
20	Biomarker results from theAVADO phase 3 trial of first - line bevacizumab plus docetaxel forHER -2 negative metastatic breast cancer显示文摘	Miles DW Haas SL Dirix LY	2013	Br J Cancer2013，108，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示